We are live on ! Find out more
TCON

TRACON Pharmaceuticals

Delisted

TCON was delisted on the 27th of June, 2024.

22 hedge funds and large institutions have $30.6M invested in TRACON Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

1.12% less ownership

Funds ownership: 37.23% → 36.1% (-1.1%)

4% less funds holding

Funds holding: 23 → 22 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

72% less capital inflows, than outflows

Capital inflows: $397K | Capital outflows: $1.42M

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TCON Hedge Fund Activity: Q1 2016 in Review

22 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in TRACON Pharmaceuticals (TCON) for Q1 2016, worth a combined $30.6M — down 27% from $41.9M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of TCON and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Vanguard Group, adding an estimated $282K. The largest seller was Deerfield Management, cutting an estimated $626K.

  • 22 institutional investors held TRACON Pharmaceuticals (TCON) as of Q1 2016, down from 23 in Q4 2015.
  • Funds reported $30.6M of TRACON Pharmaceuticals stock for Q1 2016, down 27% quarter-over-quarter.
  • 2 funds opened new TRACON Pharmaceuticals positions in Q1 2016 and 3 closed out, a net change of -1 holder.
  • The largest TRACON Pharmaceuticals buyer in Q1 2016 was Vanguard Group, an estimated $282K added.
  • The largest TRACON Pharmaceuticals seller in Q1 2016 was Deerfield Management, an estimated $626K sold.

Based on aggregated 13F filings for Q1 2016.